Targeting Peptide Products
What Are Targeting Peptides?
Targeting peptides (TPs) represent a formidable class of short amino acid sequences, typically ranging from 3 to 30 residues, that function as highly specialized "molecular guides." Their defining characteristic is the remarkable ability to specifically bind to unique receptors, antigens, or other markers that are overexpressed on the surface of diseased cells, such as tumor cells or inflamed tissue. Unlike non-specific delivery mechanisms, TPs act as a biological "ZIP code," guiding their attached therapeutic or diagnostic cargo directly to the cellular address of interest. This precise homing mechanism concentrates the payload exactly where it is needed most, forming the foundation for next-generation therapeutics that dramatically minimize off-target effects and systemic toxicity. Are you struggling to ensure your therapeutic agent reaches its intended target without collateral damage? This is the unparalleled precision that targeting peptides provide.
Fig.1 Brain-targeted therapeutic delivery using peptide-functionalized nanosystems.1
The Strategic Advantages of Peptide-Guided Delivery
The adoption of targeting peptides in drug development is driven by a unique combination of strategic benefits that overcome the limitations of larger biologics or conventional small molecules. Their power lies in their balance of simplicity and high-level function.
Exceptional Specificity and Affinity: TPs can be discovered or rationally designed to bind to their targets with incredible precision, often rivaling the affinity of much larger antibodies. This allows them to meticulously distinguish diseased cells from healthy ones.
Low Immunogenicity: As small, often natural-mimicking molecules, peptides typically avoid triggering the strong immune responses that can plague larger protein-based therapeutics, making them safer for potential repeat dosing.
Superior Tissue Penetration: Their small hydrodynamic size is a critical advantage. TPs can diffuse more readily into dense tissues, most notably penetrating solid tumors far more effectively than bulky antibodies, which are often confined to perivascular regions.
Manufacturing and Versatility: As synthetic molecules, TPs benefit from rapid, scalable, and highly cost-effective chemical synthesis. This synthetic nature makes them a supremely versatile platform. They can be reliably and precisely conjugated to a vast array of cargos, including small molecule drugs, oligonucleotides (siRNA/ASO), nanoparticles, and imaging agents.
Key Applications in Research and Drug Development
The modularity of targeting peptides has unlocked potent new strategies across numerous therapeutic and diagnostic fields. Their impact is most profound in areas where precision is paramount.
Targeted Oncology
This remains the largest and most successful application. Peptides that target receptors abundant on tumors—such as specific integrins, somatostatin receptors, or growth factor receptors—are used extensively. When linked to potent cytotoxic drugs, they create "peptide-drug conjugates" (PDCs) that internalize and kill cancer cells while sparing healthy tissue.
Precision Diagnostics and In Vivo Imaging
When conjugated to imaging agents like fluorescent dyes or radioisotopes, TPs become powerful molecular probes. They "light up" specific cell populations, enabling highly sensitive, non-invasive applications such as early disease detection, surgical guidance (tumor margin visualization), and real-time monitoring of therapeutic response.
Inflammatory and Cardiovascular Disorders
TPs can be engineered to home in on markers of inflammation (e.g., VCAM-1) or activated platelets. This allows for the targeted delivery of potent anti-inflammatory or anti-thrombotic agents directly to the site of disease, avoiding the systemic complications of these powerful drugs.
From preclinical imaging to novel oncology platforms, the applications are vast. Which specific cell type or disease model are you aiming for? Our team can help you select or custom-design the perfect peptide guide.
Partner with Creative Biolabs for Your Targeting Needs
Advancing a targeted therapeutic from concept to clinic requires more than just a peptide; it requires a deep expertise in peptide chemistry, bioconjugation, and validation. At Creative Biolabs, we are not just a vendor—we are your development partner. We provide a comprehensive suite of services built on years of technical expertise.
- Extensive Portfolio: A broad catalog of high-purity, validated targeting peptides ready for immediate use.
- Custom Peptide Synthesis: From simple sequences to complex, modified peptides, our experts will synthesize the exact molecule you require.
- Expert Bioconjugation Services: This is the critical step. We possess the robust and stable chemistries to flawlessly link your peptide to any payload, whether it's a small molecule, an oligonucleotide, or a nanoparticle.
Explore our extensive catalog of high-purity, sequence-verified targeting peptides. Our portfolio includes well-characterized sequences for a variety of common targets, all ready for immediate shipment and validation in your models. Don't let delivery and specificity challenges stall your critical research. Contact our technical specialists today. Let's collaborate to design the optimal targeting strategy for your unique payload and achieve the precision your research demands.
Can't find the specific sequence or modification you need for your project? Our custom synthesis team is ready to create it for you. Inquire about a custom-designed peptide now.
Reference
- Tang, Sophia et al. "Peptide-functionalized nanoparticles for brain-targeted therapeutics." Drug delivery and translational research, 10.1007/s13346-025-01840-w. 31 Mar. 2025. https://doi.org/10.1007/s13346-025-01840-w. Under open access license CC BY 4.0, without modification.
Filter By Clear All
-
-
CXCL8 (54-72) Targeting Peptide (CAT#: OLY-1025-YS-1)
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
LSD Targeting Peptide (CAT#: OLY-1025-YS-2)
- Cas No.: 945245-76-1
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Octreotide Targeting Peptide (CAT#: OLY-1025-YS-3)
- Cas No.: 83150-76-9
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Octreotide Pamoate Targeting Peptide (CAT#: OLY-1025-YS-4)
- Cas No.: 135467-16-2
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Cyclic(YCDGFYACYMDV) Targeting Peptide (CAT#: OLY-1025-YS-6)
- Cas No.: 535959-77-4
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
C16Y Targeting Peptide (CAT#: OLY-1025-YS-7)
- Cas No.: 640756-12-3
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
PSMA Targeting Peptide (CAT#: OLY-1025-YS-8)
- Cas No.: 2042750-71-8
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Osteocalcin (1-49) (human) Targeting Peptide (CAT#: OLY-1025-YS-9)
- Cas No.: 136461-80-8
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Aminopeptidase N Ligand (CD13) NGR Targeting Peptide (CAT#: OLY-1025-YS-10)
- Cas No.: 760947-20-4
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
GB-6 Targeting Peptide (CAT#: OLY-1025-YS-11)
- Cas No.: 2413262-74-3
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
CooP Targeting Peptide (CAT#: OLY-1025-YS-12)
- Cas No.: 1192864-27-9
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
FRα-targeting Peptide C7 (CAT#: OLY-1025-YS-13)
- Cas No.: 2159055-74-8
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Rabies Virus Matrix Protein Fragment (RV-MAT) (CAT#: OLY-1025-YS-14)
- Cas No.: 1023648-37-4
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
H-Gly-Arg-Gly-Asp-Ser-NH2 Targeting Peptide (CAT#: OLY-1025-YS-15)
- Cas No.: 143648-02-6
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
293P-1 Targeting Peptide (CAT#: OLY-1025-YS-17)
- Cas No.: 1465746-23-9
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
CREKA Targeting Peptide (CAT#: OLY-1025-YS-18)
- Cas No.: 847058-45-1
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
rTAT Targeting Peptide (CAT#: OLY-1025-YS-20)
- Cas No.: 849431-85-2
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
CK3 Targeting Peptide (CAT#: OLY-1025-YS-22)
- Cas No.: 1801552-75-9
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- Cas No.: 1332850-08-4
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
LinTT1 Targeting Peptide (CAT#: OLY-1025-YS-24)
- Cas No.: 2031154-77-3
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
GPLGLAGGWGERDGS Targeting Peptide (CAT#: OLY-1025-YS-25)
- Cas No.: 1449337-90-9
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
CGGRGD Targeting Peptide (CAT#: OLY-1025-YS-26)
- Cas No.: 1260223-44-6
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
CGGK Targeting Peptide (CAT#: OLY-1025-YS-27)
- Cas No.: 1253739-14-8
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
F3 Targeting Peptide (CAT#: OLY-1025-YS-28)
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
mUNO Targeting Peptide (CAT#: OLY-1025-YS-29)
- Cas No.: 2283322-63-2
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
IETP2 Targeting Peptide (CAT#: OLY-1025-YS-30)
- Cas No.: 2314338-36-6
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
MH42 Targeting Peptide (CAT#: OLY-1025-YS-31)
- Cas No.: 2950154-05-7
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
VSLRGDTRG Targeting Peptide (CAT#: OLY-1025-YS-32)
- Cas No.: 2027476-29-3
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Cys-PKHB1 Targeting Peptide (CAT#: OLY-1025-YS-33)
- Cas No.: 2378833-51-1
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Thrombin-cleavable Targeting Peptide (CAT#: OLY-1025-YS-34)
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Cys-SP94 Targeting Peptide (CAT#: OLY-1025-YS-35)
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Cyclo(Arg-Ala-Asp-(D-Tyr)-Lys) Targeting Peptide (CAT#: OLY-1025-YS-36)
- Cas No.: 1193347-53-3
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
GPC3 Targeting Peptide 1 (CAT#: OLY-1025-YS-37)
- Cas No.: 3066113-41-2
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
NGR Targeting Peptide (CAT#: OLY-1025-YS-38)
- Cas No.: 651328-78-8
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Cyclic SSTR Agonist Octreotide (CAT#: OLY-1025-YS-39)
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
M2 Targeting Peptide (CAT#: OLY-1025-YS-40)
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Pep2 Targeting Peptide (CAT#: OLY-1025-YS-41)
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
CXCL9(74-103) Targeting Peptide (CAT#: OLY-1025-YS-42)
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
FFAGLDD Targeting Peptide (CAT#: OLY-1025-YS-43)
- Cas No.: 2703745-70-2
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Bonemarrow-Derived Mesenchymal Stem Cells Affinity Peptide (CAT#: OLY-1025-YS-44)
- Cas No.: 683750-83-6
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Thrombospondin-1 (1016-1021) (human, Bovine, Mouse) Targeting Peptide (CAT#: OLY-1025-YS-45)
- Cas No.: 149234-06-0
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Cyclo(RGDfK(Mal)) Targeting Peptide (CAT#: OLY-1025-YS-46)
- Cas No.: 1228992-90-2
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Cyclo(Arg-Gly-Asp-D-Phe-Val) Targeting Peptide (CAT#: OLY-1025-YS-47)
- Cas No.: 137813-35-5
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
- Cas No.: 1926163-30-5
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
FFAGLDD TFA Targeting Peptide (CAT#: OLY-1025-YS-49)
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
NBD-LLLLpY Targeting Peptide (CAT#: OLY-1025-YS-50)
- Cas No.: 2883234-17-9
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA Targeting Peptide (CAT#: OLY-1025-YS-51)
- Cas No.: 199807-33-5
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Cyclo(RGDyK) Targeting Peptide (CAT#: OLY-1025-YS-52)
- Cas No.: 217099-14-4
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Cyclo(-RGDfK) TFA Targeting Peptide (CAT#: OLY-1025-YS-53)
- Cas No.: 500577-51-5
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
-
-
Cyclo(RGDyK) TFA Targeting Peptide (CAT#: OLY-1025-YS-54)
- Cas No.: 250612-42-1
- Product Type: Targeting Peptide
- Physical State: Solid
- Purity: > 95%
- Datasheet MSDS Inquiry Now
-
Filter By Tag
